| Target and Pathway |
Top |
| Target(s) |
5-HT 1A receptor (HTR1A) |
Target Info
|
Ligand |
[1] |
| 5-HT 2A receptor (HTR2A) |
Target Info
|
Ligand |
[1] |
| Dopamine D2 receptor (D2R) |
Target Info
|
Ligand |
[1] |
| Dopamine D3 receptor (D3R) |
Target Info
|
Ligand |
[1] |
| Target's Patent Info |
5-HT 1A receptor (HTR1A) |
Target's Patent Info
|
[1] |
| 5-HT 2A receptor (HTR2A) |
Target's Patent Info
|
[1] |
| Dopamine D2 receptor (D2R) |
Target's Patent Info
|
[1] |
| Dopamine D3 receptor (D3R) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
Rap1 signaling pathway
|
|
cAMP signaling pathway
|
|
Neuroactive ligand-receptor interaction
|
|
Gap junction
|
|
Dopaminergic synapse
|
|
Parkinson's disease
|
|
Cocaine addiction
|
|
Alcoholism
|
|
Serotonergic synapse
|
|
Calcium signaling pathway
|
|
Inflammatory mediator regulation of TRP channels
|
|
Panther Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
|
Dopamine receptor mediated signaling pathway
|
|
Nicotine pharmacodynamics pathway
|
|
5HT1 type receptor mediated signaling pathway
|
|
5HT2 type receptor mediated signaling pathway
|
|
Reactome
|
Dopamine receptors
|
|
G alpha (i) signalling events
|
|
Serotonin receptors
|
|
G alpha (q) signalling events
|
|
WikiPathways
|
Hypothetical Network for Drug Addiction
|
|
Monoamine GPCRs
|
|
GPCRs, Class A Rhodopsin-like
|
|
Genes and (Common) Pathways Underlying Drug Addiction
|
|
GPCR ligand binding
|
|
GPCR downstream signaling
|
|
Nicotine Activity on Dopaminergic Neurons
|
|
Serotonin HTR1 Group and FOS Pathway
|
|
SIDS Susceptibility Pathways
|
|
Serotonin Receptor 2 and STAT3 Signaling
|
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
|
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
|
GPCRs, Other
|
